These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35879931)

  • 1. Psychometric Validation of the Haemo-QOL-A in Participants with Hemophilia A Treated with Gene Therapy.
    Quinn J; Delaney KA; Wong WY; Miesbach W; Bullinger M
    Patient Relat Outcome Meas; 2022; 13():169-180. PubMed ID: 35879931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
    O'Mahony B; Dunn AL; Leavitt AD; Peyvandi F; Ozelo MC; Mahlangu J; Peerlinck K; Wang JD; Lowe GC; Tan CW; Giermasz A; Tran H; Khoo TL; Cockrell E; Pepperell D; Chambost H; López Fernández MF; Kazmi R; Majerus E; Skinner MW; Klamroth R; Quinn J; Yu H; Wong WY; Robinson TM; Pipe SW
    J Thromb Haemost; 2023 Dec; 21(12):3450-3462. PubMed ID: 37678546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia.
    Rentz A; Flood E; Altisent C; Bullinger M; Klamroth R; Garrido RP; Scharrer I; Schramm W; Gorina E;
    Haemophilia; 2008 Sep; 14(5):1023-34. PubMed ID: 18665853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.
    Pasi KJ; Laffan M; Rangarajan S; Robinson TM; Mitchell N; Lester W; Symington E; Madan B; Yang X; Kim B; Pierce GF; Wong WY
    Haemophilia; 2021 Nov; 27(6):947-956. PubMed ID: 34378280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    Ozelo MC; Mahlangu J; Pasi KJ; Giermasz A; Leavitt AD; Laffan M; Symington E; Quon DV; Wang JD; Peerlinck K; Pipe SW; Madan B; Key NS; Pierce GF; O'Mahony B; Kaczmarek R; Henshaw J; Lawal A; Jayaram K; Huang M; Yang X; Wong WY; Kim B;
    N Engl J Med; 2022 Mar; 386(11):1013-1025. PubMed ID: 35294811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
    Pasi KJ; Rangarajan S; Mitchell N; Lester W; Symington E; Madan B; Laffan M; Russell CB; Li M; Pierce GF; Wong WY
    N Engl J Med; 2020 Jan; 382(1):29-40. PubMed ID: 31893514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis.
    Cheung PWH; Wong CKH; Samartzis D; Luk KDK; Lam CLK; Cheung KMC; Cheung JPY
    Scoliosis Spinal Disord; 2016; 11():19. PubMed ID: 27525314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Added Value of the EQ-5D-5L With Two Bolt-On Items in Patients With Hemophilia.
    Xu RH; Dong D; Luo N; Yang R; Liu J; Zhang S
    Front Med (Lausanne); 2021; 8():707998. PubMed ID: 34422863
    [No Abstract]   [Full Text] [Related]  

  • 9. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
    Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
    AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia-Specific Quality of Life Index (Haemo-QoL and Haem-A-QoL questionnaires) of children and adults: result of a single center from Turkey.
    Mercan A; Sarper N; Inanir M; Mercan HI; Zengin E; Kiliç SÇ; Gökalp AS
    Pediatr Hematol Oncol; 2010 Sep; 27(6):449-61. PubMed ID: 20615067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore.
    Seng JJB; Kwan YH; Fong W; Phang JK; Lui NL; Thumboo J; Leung YY
    Eur J Rheumatol; 2020 Apr; 7(2):71-78. PubMed ID: 32644927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability test of the Indonesian version of the PedHALshort questionnaire.
    Chozie NA; Ayu DR; Medise BE; Marsubrin PMT; Sari TT; Yuniar I; Wahyuni LK
    Haemophilia; 2024 May; 30(3):728-732. PubMed ID: 38578181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisolone Does Not Regulate Factor VIII Expression in Mice Receiving AAV5-hFVIII-SQ: Valoctocogene Roxaparvovec.
    Zhang L; Handyside B; Murphy R; Sihn CR; Xie L; Vitelli C; Harmon D; Sisó S; Liu S; Bullens S; Bunting S; Fong S
    Mol Ther Methods Clin Dev; 2020 Jun; 17():13-20. PubMed ID: 31890737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
    Mahlangu J; Kaczmarek R; von Drygalski A; Shapiro S; Chou SC; Ozelo MC; Kenet G; Peyvandi F; Wang M; Madan B; Key NS; Laffan M; Dunn AL; Mason J; Quon DV; Symington E; Leavitt AD; Oldenburg J; Chambost H; Reding MT; Jayaram K; Yu H; Mahajan R; Chavele KM; Reddy DB; Henshaw J; Robinson TM; Wong WY; Pipe SW;
    N Engl J Med; 2023 Feb; 388(8):694-705. PubMed ID: 36812433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
    Batt K; Recht M; Cooper DL; Iyer NN; Kempton CL
    Patient Prefer Adherence; 2017; 11():1369-1380. PubMed ID: 28860720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
    Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of the Haem-A-QoL in haemophilia clinical trials.
    von Mackensen S; Eldar-Lissai A; Auguste P; Krishnan S; von Maltzahn R; Yu R; Wyrwich KW
    Haemophilia; 2017 May; 23(3):383-391. PubMed ID: 28026074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
    Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
    Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.